期刊文献+

UPLC法测定大鼠血浆中Liguzinediol浓度以及动力学研究 被引量:10

Determination of Liguzinediol and its pharmacokinetics in rat by ultra performance of liquid chromatograph
下载PDF
导出
摘要 目的建立测定大鼠血浆中Liguzinediol浓度的UPLC测定方法,探讨其在大鼠体内的药代动力学。方法血浆样品经甲醇提取后,上清液经N2吹干流动相复溶后注入UPLC分析,色谱柱为UPLC HSS T3柱(2.1 mm×100 mm,1.8μm),流动相为甲醇-水(28∶72,V∶V),流速为0.4 ml.min-1,检测波长278 nm。SD大鼠6只,iv给药10 mg.kg-1后,用UPLC法测定给药后大鼠血浆中Liguzinediol的浓度,利用DAS软件拟合并计算其药代动力学参数。结果 Ligu-zinediol的血药浓度在0.41~52.4 mg.L-1范围内呈线性,提取回收率均>80%,日内、日间精密度<10%,符合生物样品分析要求。大鼠静脉注射10 mg.kg-1的Liguzinediol,其血药浓度(C)-时间(t)曲线呈二室模型,主要药动学参数T12β、AUC(0-∞)、CL分别为1.62 h、18.36 mg.h.L-1、0.71 L.h-1.kg-1。结论该方法操作简便、快速、专属性强,可用于Liguzinediol的药代动力学及成药性研究。 Aim To establish a simple and accurate method for determination of Liguzinediol by ultra performance liquid chromatography(UPLC) and study the pharmacokinetics of Liguzinediol in rats.Methods Liguzinediol was extracted from plasma with methanol,and analyzed by UPLC with an Acquity UPLC HSS T3 column(2.1 mm×100 mm,1.8 μm) at 278 nm.Methanol and water(28 ∶ 72) were used as the mobile phase.The flow rate was 0.4 ml·min^-1.Six rats was given 10 mg·kg^-1 Liguzinediol via iv,drug plasma concentration was determined by UPLC and pharmacokinetic parameters were evaluated by DAS Software.Results Calibration curve was linear within the range of 0.41-52.4 mg·L^-1.The extract recoveries of Liguzinediol were more than 80%.RSD of inter-day and intra-day assay was limited in 10%.The concentration-time courses of liguzinediol were best fitted to a two compartment open model.The main pharmacokinetic parameters of T1 2β,AUC(0-∞),CL were 1.62 h,18.36 mg·h·L^-1,0.71 L·h^-1·kg^-1 respectively.Conclusions The method is simple,rapid and accurate.It has a good reproducibility and stability,which may be used for plasma concentration monitoring and pharmacokinetics study for Liguzinediol.
出处 《中国药理学通报》 CAS CSCD 北大核心 2011年第5期709-712,共4页 Chinese Pharmacological Bulletin
基金 科技部"重大新药创制"科技重大专项资助项目(No2009ZX09103-081) 国家自然科学基金资助项目(No81072542)
关键词 LIGUZINEDIOL UPLC 药代动力学 血药浓度 大鼠 测定 Liguzinediol UPLC pharmacokinetics plasma concentration rat determination
  • 相关文献

参考文献5

二级参考文献46

共引文献72

同被引文献58

  • 1施铮,徐毅,周淑媛,彭国平,陈龙.双黄连粉针剂对豚鼠心肌电生理的影响[J].中国药理学与毒理学杂志,2010,24(6):455-459. 被引量:6
  • 2唐瑞仁,郑由浒,赵强,严子耳.4-羟基吡啶-2,6-二甲酸二甲酯合成工艺研究[J].化学反应工程与工艺,2006,22(1):83-87. 被引量:5
  • 3李小双,王清清,孙效,欧伦,朱宝珍,尚明美,宋海峰.自动化在线固相萃取HPLC/MS/MS法分析比格犬血浆中的葛根素含量[J].军事医学科学院院刊,2007,31(3):246-249. 被引量:4
  • 4FARGNOLI AS, KATZ MG, YARNALL C, et a/. A pharmaco- kinetic analysis of molecular cardiac surgery with recirculation mediated delivery of betaarkct gene therapy: developing a quantitative definition of the therapeutic window[J]. J Card Fail, 2011, 17(8): 691-699.
  • 5CHEN WD, LIANG Y, WANG GJ, et d. Pharmacokinetics of the ginkgo B following intravenous administration of ginkgo B emulsion in rats[J]. Biol Pharm Bull, 2007, 30 ( 1 ) : 1-5.
  • 6LIU CX, LIU DY. Introduction to pharamcokinetics [M]. Beijing: Science Press, 1980: 6-10.
  • 7SMITH BP, VANDENHENDE FR, DESANTE KA, et al. Confidence interval criteria for assessment of dose proportionality [J]. Pharm Res, 2000, 17 (10): 1278-1283.
  • 8刘静.Liguzinedioi先导物的发现及正性肌力活性研究[D].南京中医药大学,2009:14 -15.
  • 9CHEN L, XU Y, LI W,et al. The novel compound liguzinediolexerts positive inotropic effects in isolated rat heart via sarcoplas-mic reticulum Ca2+ ATPase-dependent mechanism [ J]. Life Sci,2012,91(11) : 402 -409.
  • 10SHAN CX,LI W,WEN HM, et al. Identification of liguzinediolmetabolites in rats by ultra performance liquid chromatography/quadrupole-time-of-flight mass spectrometry [ J ]. J Pharm Bi-omed Anal, 2012, 62(3) : 187 - 190.

引证文献10

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部